As of 2024-12-11, the Intrinsic Value of Cipher Pharmaceuticals Inc (CPH.TO) is
18.55 CAD. This CPH.TO valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 16.00 CAD, the upside of Cipher Pharmaceuticals Inc is
16.00%.
The range of the Intrinsic Value is 9.69 - 116.15 CAD
18.55 CAD
Intrinsic Value
CPH.TO Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
9.69 - 116.15 |
18.55 |
16.0% |
| DCF (Growth 10y) |
10.67 - 115.25 |
19.42 |
21.3% |
| DCF (EBITDA 5y) |
4.91 - 7.08 |
6.39 |
-60.0% |
| DCF (EBITDA 10y) |
6.20 - 8.73 |
7.79 |
-51.3% |
| Fair Value |
21.93 - 21.93 |
21.93 |
37.08% |
| P/E |
12.79 - 16.12 |
14.71 |
-8.1% |
| EV/EBITDA |
0.93 - 6.46 |
3.57 |
-77.7% |
| EPV |
6.71 - 9.14 |
7.93 |
-50.5% |
| DDM - Stable |
16.44 - 232.22 |
124.33 |
677.1% |
| DDM - Multi |
13.31 - 144.01 |
24.22 |
51.4% |
CPH.TO Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
409.43 |
| Beta |
-1.93 |
| Outstanding shares (mil) |
25.59 |
| Enterprise Value (mil) |
453.64 |
| Market risk premium |
5.10% |
| Cost of Equity |
5.54% |
| Cost of Debt |
5.00% |
| WACC |
5.54% |